# OSELTAMIVIR PHOSPHATE
> **ANDA209113** · Abbreviated New Drug Application (Generic) · Sponsor: ZYDUS PHARMS · Approved 2017-09-14
## Drug
- **FDA Application Number:** ANDA209113
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** OSELTAMIVIR PHOSPHATE
- **Generic name:** OSELTAMIVIR ACID
- **Active ingredients:** OSELTAMIVIR PHOSPHATE
- **Dosage form:** FOR SUSPENSION
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ZYDUS PHARMS
- **Manufacturer:** Zydus Lifesciences Limited
- **First approval:** 2017-09-14
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209113)
---
*MORVS · CC0 1.0*